Health
Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved – Monthly Prescribing Reference
Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.
The Food and Drug Administration (FDA) has approved a multidose vial presentation of Audenz (influenza A
Continue Reading
-
Noosa News15 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business17 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Business22 hours agoIs AustralianSuper buying or selling Telstra and CSL shares?
-
Noosa News17 hours agoAnother whale calf caught in Noosa nets